Featured Articles

1. The Phase 2 Manufacturing Wall: The CMC Risk Hiding In Plain Sight 9/17/2026

   Hidden gaps in process maturity and organizational alignment can derail development. Discover how to identify risks early and improve readiness for key milestones.

2. AI Pilots And Strategic Partnerships 9/17/2026

   Geopolitical uncertainty is reshaping outsourced manufacturing. Discover how industry leaders are leveraging AI, enhancing partnerships, and strengthening supply networks.

3. Vertex On Building Risk Into Manufacturing Network Strategy 9/17/2026

   Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.

4. How Sandoz Cut Its Supplier Network By 34%: A Consolidation Playbook 8/3/2026

   Sandoz cut its finished dose form supplier network by 34% in two years. Get the six-step make-vs-buy framework and three-phase consolidation approach that made it possible.

5. Target Product Profile (TPP) Explained 7/27/2026

   Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.

6. Drug Development Readiness: Interactive Checklist And RACI 7/27/2026

   Early decisions can have long-lasting consequences for development timelines, cost, risk, and overall probability of success. Engaging the appropriate disciplines early helps avoid downstream surprises and rework.

7. Drug Development Plan Explained: DPP Templates And Examples 7/27/2026

   Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.